AffiAB® Anti-GTPBP4 Antibody [JE47-47]
GTP-binding proteins are GTPases and function as molecular switches that can flip between two states: active, when GTP is bound, and inactive, when GDP is bound. 'Active' in this context usually means that the molecule acts as a signal to trigger other events in the cell. When an extracellular ligand binds to a G-protein-linked receptor, the receptor changes its conformation and switches on the trimeric G proteins that associate with it by causing them to eject their GDP and replace it with GTP. The switch is turned off when the G protein hydrolyzes its own bound GTP, converting it back to GDP. But before that occurs, the active protein has an opportunity to diffuse away from the receptor and deliver its message for a prolonged period to its downstream target.
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: Q9BZE4 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
JE47-47
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IHC-P, FC
Predicted species reactivity
N/A
Immunogen
Recombinant protein within Human GTPBP4 aa 1-131 / 634.
Storage
Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
N/A
Recommended dilutions
WB:1:500
; IHC-P:1:50-1:500
; FC:1:50-1:100
Molecular Weight
Predicted band size: 74 kDa
Subcellular location
Nucleus.
Positive control
293T cell lysates, human liver carcinoma tissue, human thyroid tissue, human skin tissue, human breast tissue, THP-1, human tonsil tissue, human lung tissue, human cervix tissue, human colon carcinoma tissue, human prostate tissue, human breast carcinoma tissue, human stomach carcinoma tissue, human small intestine tissue.